Strong and specific elimination of enhanced IL-7R-positive cells, as a common pathogenesis of both lymphoid malignancy and autoimmune disease, might prevent the development of malignancy or autoimmune disease in high-risk patients. Here, IL7R is linked to autoimmune disease.